Scholarly Index
Gert Van Assche
KU Leuven; 59,217 total citations; 719 total publications; best world rank #10
KU Leuven
59,217Total citations
719Total publications
111H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Genetics | Lifetime | 61 | BE 3 | 99.88 |
| Epidemiology | Lifetime | 680 | BE 11 | 99.14 |
| Gastroenterology | Lifetime | 485 | BE 13 | 90.35 |
| Inflammatory Bowel Disease | Lifetime | 13 | BE 3 | 99.90 |
| Microscopic Colitis | Lifetime | 13 | BE 3 | 99.88 |
| Autoimmune and Inflammatory Disorders | Lifetime | 10 | BE 3 | 99.84 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 56 | BE 3 | 99.63 |
| Diverticular Disease and Complications | Lifetime | 37 | BE 1 | 99.44 |
| Helicobacter pylori-related gastroenterology studies | Lifetime | 375 | BE 8 | 98.56 |
| Eosinophilic Esophagitis | Lifetime | 272 | BE 9 | 98.54 |
| Liver Diseases and Immunity | Lifetime | 168 | BE 4 | 98.47 |
| Celiac Disease Research and Management | Lifetime | 192 | BE 5 | 96.94 |
| Diagnosis and treatment of tuberculosis | Lifetime | 475 | BE 7 | 94.48 |
| Anorectal Disease Treatments and Outcomes | Lifetime | 503 | BE 6 | 95.69 |
| Biosimilars and Bioanalytical Methods | Lifetime | 511 | BE 17 | 92.78 |
| IL-33, ST2, and ILC Pathways | Lifetime | 794 | BE 16 | 93.25 |